カテゴリー： Market Monitor Global, 世界, 医療/バイオ

がん薬物治療の世界市場見通し2023年-2029年

◆英語タイトル：Cancer Drug Therapy Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8387 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：119 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Cancer Drug Therapy Market 調査レポートは次の情報を含め、グローバルにおけるのがん薬物治療市場規模と予測を収録しています。・世界のがん薬物治療市場：売上、2018年-2023年、2024年-2029年
・世界のがん薬物治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のがん薬物治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「標的治療」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

がん薬物治療のグローバル主要企業は、Amgen / Allergan、 Argos Therapeutics、 AstraZeneca、 Aveo Pharmaceuticals、 Bayer、 Exelixis、 Incyte、 Merck、 Roche、 Bristol-Myers Squibb、 Eisai、 Exelixis、 Genentech (Roche)、 Novartis、 Pfizer、 Prometheus Labsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、がん薬物治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のがん薬物治療市場：タイプ別、2018年-2023年、2024年-2029年
世界のがん薬物治療市場：タイプ別市場シェア、2022年
・標的治療、化学治療、免疫治療

世界のがん薬物治療市場：用途別、2018年-2023年、2024年-2029年
世界のがん薬物治療市場：用途別市場シェア、2022年
・血管新生阻害剤、mTOR阻害剤、モノクローナル抗体、サイトカイン免疫治療（IL-2）

世界のがん薬物治療市場：地域・国別、2018年-2023年、2024年-2029年
世界のがん薬物治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるがん薬物治療のグローバル売上、2018年-2023年
・主要企業におけるがん薬物治療のグローバル売上シェア、2022年
・主要企業におけるがん薬物治療のグローバル販売量、2018年-2023年
・主要企業におけるがん薬物治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Amgen / Allergan、 Argos Therapeutics、 AstraZeneca、 Aveo Pharmaceuticals、 Bayer、 Exelixis、 Incyte、 Merck、 Roche、 Bristol-Myers Squibb、 Eisai、 Exelixis、 Genentech (Roche)、 Novartis、 Pfizer、 Prometheus Labs

*************************************************************

・調査・分析レポートの概要
がん薬物治療市場の定義
市場セグメント
世界のがん薬物治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のがん薬物治療市場規模
世界のがん薬物治療市場規模：2022年 VS 2029年
世界のがん薬物治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのがん薬物治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のがん薬物治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：標的治療、化学治療、免疫治療
がん薬物治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：血管新生阻害剤、mTOR阻害剤、モノクローナル抗体、サイトカイン免疫治療（IL-2）
がん薬物治療の用途別グローバル売上・予測

・地域別市場分析
地域別がん薬物治療市場規模 2022年と2029年
地域別がん薬物治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Amgen / Allergan、 Argos Therapeutics、 AstraZeneca、 Aveo Pharmaceuticals、 Bayer、 Exelixis、 Incyte、 Merck、 Roche、 Bristol-Myers Squibb、 Eisai、 Exelixis、 Genentech (Roche)、 Novartis、 Pfizer、 Prometheus Labs
...

Kidney cancer or renal cancer is one of the ten most frequently diagnosed cancers, found mainly in people aged 60 or above. According to the estimates of the American Cancer Society (ACS), 61,560 new kidney cancer cases and 14,080 deaths would occur in 2015. Due to the increasing prevalence with no cure of this deadly disease, till date, there is an imminent need for effective kidney cancer drugs.

The renal cancer drug therapy market has witnessed a dramatic change in its treatment paradigm over the last three decades. Although, there are a variety of treatment options available, innovators have now shifted their focus towards more targeted therapies and immunotherapies. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors boosting the growth of the market. Strong pipeline and fast-emerging treatments are expected to further boost the market during the analysis period. However, high cost of drugs, looming off-patents and uncertain reimbursement policies are some of the factors that are likely to restrain the market growth.

Winning a physicians confidence regarding the cost, efficacy and dosage would lead to a higher acceptance of drugs in the market. Additionally, immunotherapies would emerge as an opportunity for innovators in the kidney cancer drugs market. Furthermore, untapped geographies with a high undiagnosed patient base would offer lucrative opportunities for the innovators in future. However, overcoming the generic drugs competition would be a key challenge for the leading innovators.
This report aims to provide a comprehensive presentation of the global market for Cancer Drug Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Drug Therapy. This report contains market size and forecasts of Cancer Drug Therapy in global, including the following market information:
Global Cancer Drug Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Cancer Drug Therapy Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Cancer Drug Therapy companies in 2022 (%)
The global Cancer Drug Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Targeted Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Drug Therapy include Amgen / Allergan, Argos Therapeutics, AstraZeneca, Aveo Pharmaceuticals, Bayer, Exelixis, Incyte, Merck and Roche, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Drug Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Drug Therapy Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Drug Therapy Market Segment Percentages, by Type, 2022 (%)
Targeted Therapy
Chemotherapy
Immunotherapy
Global Cancer Drug Therapy Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Drug Therapy Market Segment Percentages, by Application, 2022 (%)
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
Global Cancer Drug Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cancer Drug Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Drug Therapy revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cancer Drug Therapy revenues share in global market, 2022 (%)
Key companies Cancer Drug Therapy sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Cancer Drug Therapy sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen / Allergan
Argos Therapeutics
AstraZeneca
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Merck
Roche
Bristol-Myers Squibb
Eisai
Exelixis
Genentech (Roche)
Novartis
Pfizer
Prometheus Labs
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Drug Therapy, market overview.
Chapter 2: Global Cancer Drug Therapy market size in revenue and volume.
Chapter 3: Detailed analysis of Cancer Drug Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Drug Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cancer Drug Therapy capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Cancer Drug Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Drug Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Drug Therapy Overall Market Size
2.1 Global Cancer Drug Therapy Market Size: 2022 VS 2029
2.2 Global Cancer Drug Therapy Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Cancer Drug Therapy Sales: 2018-2029
3 Company Landscape
3.1 Top Cancer Drug Therapy Players in Global Market
3.2 Top Global Cancer Drug Therapy Companies Ranked by Revenue
3.3 Global Cancer Drug Therapy Revenue by Companies
3.4 Global Cancer Drug Therapy Sales by Companies
3.5 Global Cancer Drug Therapy Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Cancer Drug Therapy Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Cancer Drug Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cancer Drug Therapy Players in Global Market
3.8.1 List of Global Tier 1 Cancer Drug Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Cancer Drug Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Cancer Drug Therapy Market Size Markets, 2022 & 2029
4.1.2 Targeted Therapy
4.1.3 Chemotherapy
4.1.4 Immunotherapy
4.2 By Type – Global Cancer Drug Therapy Revenue & Forecasts
4.2.1 By Type – Global Cancer Drug Therapy Revenue, 2018-2023
4.2.2 By Type – Global Cancer Drug Therapy Revenue, 2024-2029
4.2.3 By Type – Global Cancer Drug Therapy Revenue Market Share, 2018-2029
4.3 By Type – Global Cancer Drug Therapy Sales & Forecasts
4.3.1 By Type – Global Cancer Drug Therapy Sales, 2018-2023
4.3.2 By Type – Global Cancer Drug Therapy Sales, 2024-2029
4.3.3 By Type – Global Cancer Drug Therapy Sales Market Share, 2018-2029
4.4 By Type – Global Cancer Drug Therapy Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Cancer Drug Therapy Market Size, 2022 & 2029
5.1.2 Angiogenesis Inhibitors
5.1.3 mTOR Inhibitors
5.1.4 Monoclonal Antibodies
5.1.5 Cytokine Immunotherapy (IL-2)
5.2 By Application – Global Cancer Drug Therapy Revenue & Forecasts
5.2.1 By Application – Global Cancer Drug Therapy Revenue, 2018-2023
5.2.2 By Application – Global Cancer Drug Therapy Revenue, 2024-2029
5.2.3 By Application – Global Cancer Drug Therapy Revenue Market Share, 2018-2029
5.3 By Application – Global Cancer Drug Therapy Sales & Forecasts
5.3.1 By Application – Global Cancer Drug Therapy Sales, 2018-2023
5.3.2 By Application – Global Cancer Drug Therapy Sales, 2024-2029
5.3.3 By Application – Global Cancer Drug Therapy Sales Market Share, 2018-2029
5.4 By Application – Global Cancer Drug Therapy Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Cancer Drug Therapy Market Size, 2022 & 2029
6.2 By Region – Global Cancer Drug Therapy Revenue & Forecasts
6.2.1 By Region – Global Cancer Drug Therapy Revenue, 2018-2023
6.2.2 By Region – Global Cancer Drug Therapy Revenue, 2024-2029
6.2.3 By Region – Global Cancer Drug Therapy Revenue Market Share, 2018-2029
6.3 By Region – Global Cancer Drug Therapy Sales & Forecasts
6.3.1 By Region – Global Cancer Drug Therapy Sales, 2018-2023
6.3.2 By Region – Global Cancer Drug Therapy Sales, 2024-2029
6.3.3 By Region – Global Cancer Drug Therapy Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Cancer Drug Therapy Revenue, 2018-2029
6.4.2 By Country – North America Cancer Drug Therapy Sales, 2018-2029
6.4.3 US Cancer Drug Therapy Market Size, 2018-2029
6.4.4 Canada Cancer Drug Therapy Market Size, 2018-2029
6.4.5 Mexico Cancer Drug Therapy Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Cancer Drug Therapy Revenue, 2018-2029
6.5.2 By Country – Europe Cancer Drug Therapy Sales, 2018-2029
6.5.3 Germany Cancer Drug Therapy Market Size, 2018-2029
6.5.4 France Cancer Drug Therapy Market Size, 2018-2029
6.5.5 U.K. Cancer Drug Therapy Market Size, 2018-2029
6.5.6 Italy Cancer Drug Therapy Market Size, 2018-2029
6.5.7 Russia Cancer Drug Therapy Market Size, 2018-2029
6.5.8 Nordic Countries Cancer Drug Therapy Market Size, 2018-2029
6.5.9 Benelux Cancer Drug Therapy Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Cancer Drug Therapy Revenue, 2018-2029
6.6.2 By Region – Asia Cancer Drug Therapy Sales, 2018-2029
6.6.3 China Cancer Drug Therapy Market Size, 2018-2029
6.6.4 Japan Cancer Drug Therapy Market Size, 2018-2029
6.6.5 South Korea Cancer Drug Therapy Market Size, 2018-2029
6.6.6 Southeast Asia Cancer Drug Therapy Market Size, 2018-2029
6.6.7 India Cancer Drug Therapy Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Cancer Drug Therapy Revenue, 2018-2029
6.7.2 By Country – South America Cancer Drug Therapy Sales, 2018-2029
6.7.3 Brazil Cancer Drug Therapy Market Size, 2018-2029
6.7.4 Argentina Cancer Drug Therapy Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Cancer Drug Therapy Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Cancer Drug Therapy Sales, 2018-2029
6.8.3 Turkey Cancer Drug Therapy Market Size, 2018-2029
6.8.4 Israel Cancer Drug Therapy Market Size, 2018-2029
6.8.5 Saudi Arabia Cancer Drug Therapy Market Size, 2018-2029
6.8.6 UAE Cancer Drug Therapy Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amgen / Allergan
7.1.1 Amgen / Allergan Company Summary
7.1.2 Amgen / Allergan Business Overview
7.1.3 Amgen / Allergan Cancer Drug Therapy Major Product Offerings
7.1.4 Amgen / Allergan Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.1.5 Amgen / Allergan Key News & Latest Developments
7.2 Argos Therapeutics
7.2.1 Argos Therapeutics Company Summary
7.2.2 Argos Therapeutics Business Overview
7.2.3 Argos Therapeutics Cancer Drug Therapy Major Product Offerings
7.2.4 Argos Therapeutics Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.2.5 Argos Therapeutics Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Cancer Drug Therapy Major Product Offerings
7.3.4 AstraZeneca Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Aveo Pharmaceuticals
7.4.1 Aveo Pharmaceuticals Company Summary
7.4.2 Aveo Pharmaceuticals Business Overview
7.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Major Product Offerings
7.4.4 Aveo Pharmaceuticals Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.4.5 Aveo Pharmaceuticals Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Cancer Drug Therapy Major Product Offerings
7.5.4 Bayer Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 Exelixis
7.6.1 Exelixis Company Summary
7.6.2 Exelixis Business Overview
7.6.3 Exelixis Cancer Drug Therapy Major Product Offerings
7.6.4 Exelixis Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.6.5 Exelixis Key News & Latest Developments
7.7 Incyte
7.7.1 Incyte Company Summary
7.7.2 Incyte Business Overview
7.7.3 Incyte Cancer Drug Therapy Major Product Offerings
7.7.4 Incyte Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.7.5 Incyte Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Cancer Drug Therapy Major Product Offerings
7.8.4 Merck Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.8.5 Merck Key News & Latest Developments
7.9 Roche
7.9.1 Roche Company Summary
7.9.2 Roche Business Overview
7.9.3 Roche Cancer Drug Therapy Major Product Offerings
7.9.4 Roche Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.9.5 Roche Key News & Latest Developments
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Company Summary
7.10.2 Bristol-Myers Squibb Business Overview
7.10.3 Bristol-Myers Squibb Cancer Drug Therapy Major Product Offerings
7.10.4 Bristol-Myers Squibb Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.10.5 Bristol-Myers Squibb Key News & Latest Developments
7.11 Eisai
7.11.1 Eisai Company Summary
7.11.2 Eisai Cancer Drug Therapy Business Overview
7.11.3 Eisai Cancer Drug Therapy Major Product Offerings
7.11.4 Eisai Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.11.5 Eisai Key News & Latest Developments
7.12 Exelixis
7.12.1 Exelixis Company Summary
7.12.2 Exelixis Cancer Drug Therapy Business Overview
7.12.3 Exelixis Cancer Drug Therapy Major Product Offerings
7.12.4 Exelixis Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.12.5 Exelixis Key News & Latest Developments
7.13 Genentech (Roche)
7.13.1 Genentech (Roche) Company Summary
7.13.2 Genentech (Roche) Cancer Drug Therapy Business Overview
7.13.3 Genentech (Roche) Cancer Drug Therapy Major Product Offerings
7.13.4 Genentech (Roche) Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.13.5 Genentech (Roche) Key News & Latest Developments
7.14 Novartis
7.14.1 Novartis Company Summary
7.14.2 Novartis Business Overview
7.14.3 Novartis Cancer Drug Therapy Major Product Offerings
7.14.4 Novartis Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.14.5 Novartis Key News & Latest Developments
7.15 Pfizer
7.15.1 Pfizer Company Summary
7.15.2 Pfizer Business Overview
7.15.3 Pfizer Cancer Drug Therapy Major Product Offerings
7.15.4 Pfizer Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.15.5 Pfizer Key News & Latest Developments
7.16 Prometheus Labs
7.16.1 Prometheus Labs Company Summary
7.16.2 Prometheus Labs Business Overview
7.16.3 Prometheus Labs Cancer Drug Therapy Major Product Offerings
7.16.4 Prometheus Labs Cancer Drug Therapy Sales and Revenue in Global (2018-2023)
7.16.5 Prometheus Labs Key News & Latest Developments
8 Global Cancer Drug Therapy Production Capacity, Analysis
8.1 Global Cancer Drug Therapy Production Capacity, 2018-2029
8.2 Cancer Drug Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Cancer Drug Therapy Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cancer Drug Therapy Supply Chain Analysis
10.1 Cancer Drug Therapy Industry Value Chain
10.2 Cancer Drug Therapy Upstream Market
10.3 Cancer Drug Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cancer Drug Therapy Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Cancer Drug Therapy in Global Market
Table 2. Top Cancer Drug Therapy Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Cancer Drug Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Cancer Drug Therapy Revenue Share by Companies, 2018-2023
Table 5. Global Cancer Drug Therapy Sales by Companies, (K Units), 2018-2023
Table 6. Global Cancer Drug Therapy Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Cancer Drug Therapy Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Cancer Drug Therapy Product Type
Table 9. List of Global Tier 1 Cancer Drug Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Drug Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Cancer Drug Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Cancer Drug Therapy Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Cancer Drug Therapy Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Cancer Drug Therapy Sales (K Units), 2018-2023
Table 15. By Type - Global Cancer Drug Therapy Sales (K Units), 2024-2029
Table 16. By Application – Global Cancer Drug Therapy Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Cancer Drug Therapy Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Cancer Drug Therapy Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Cancer Drug Therapy Sales (K Units), 2018-2023
Table 20. By Application - Global Cancer Drug Therapy Sales (K Units), 2024-2029
Table 21. By Region – Global Cancer Drug Therapy Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Cancer Drug Therapy Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Cancer Drug Therapy Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Cancer Drug Therapy Sales (K Units), 2018-2023
Table 25. By Region - Global Cancer Drug Therapy Sales (K Units), 2024-2029
Table 26. By Country - North America Cancer Drug Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Cancer Drug Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Cancer Drug Therapy Sales, (K Units), 2018-2023
Table 29. By Country - North America Cancer Drug Therapy Sales, (K Units), 2024-2029
Table 30. By Country - Europe Cancer Drug Therapy Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Cancer Drug Therapy Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Cancer Drug Therapy Sales, (K Units), 2018-2023
Table 33. By Country - Europe Cancer Drug Therapy Sales, (K Units), 2024-2029
Table 34. By Region - Asia Cancer Drug Therapy Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Cancer Drug Therapy Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Cancer Drug Therapy Sales, (K Units), 2018-2023
Table 37. By Region - Asia Cancer Drug Therapy Sales, (K Units), 2024-2029
Table 38. By Country - South America Cancer Drug Therapy Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Cancer Drug Therapy Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Cancer Drug Therapy Sales, (K Units), 2018-2023
Table 41. By Country - South America Cancer Drug Therapy Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Cancer Drug Therapy Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Cancer Drug Therapy Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Cancer Drug Therapy Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Cancer Drug Therapy Sales, (K Units), 2024-2029
Table 46. Amgen / Allergan Company Summary
Table 47. Amgen / Allergan Cancer Drug Therapy Product Offerings
Table 48. Amgen / Allergan Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Amgen / Allergan Key News & Latest Developments
Table 50. Argos Therapeutics Company Summary
Table 51. Argos Therapeutics Cancer Drug Therapy Product Offerings
Table 52. Argos Therapeutics Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Argos Therapeutics Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Cancer Drug Therapy Product Offerings
Table 56. AstraZeneca Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Aveo Pharmaceuticals Company Summary
Table 59. Aveo Pharmaceuticals Cancer Drug Therapy Product Offerings
Table 60. Aveo Pharmaceuticals Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Aveo Pharmaceuticals Key News & Latest Developments
Table 62. Bayer Company Summary
Table 63. Bayer Cancer Drug Therapy Product Offerings
Table 64. Bayer Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Bayer Key News & Latest Developments
Table 66. Exelixis Company Summary
Table 67. Exelixis Cancer Drug Therapy Product Offerings
Table 68. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Exelixis Key News & Latest Developments
Table 70. Incyte Company Summary
Table 71. Incyte Cancer Drug Therapy Product Offerings
Table 72. Incyte Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Incyte Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Cancer Drug Therapy Product Offerings
Table 76. Merck Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Merck Key News & Latest Developments
Table 78. Roche Company Summary
Table 79. Roche Cancer Drug Therapy Product Offerings
Table 80. Roche Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Roche Key News & Latest Developments
Table 82. Bristol-Myers Squibb Company Summary
Table 83. Bristol-Myers Squibb Cancer Drug Therapy Product Offerings
Table 84. Bristol-Myers Squibb Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Bristol-Myers Squibb Key News & Latest Developments
Table 86. Eisai Company Summary
Table 87. Eisai Cancer Drug Therapy Product Offerings
Table 88. Eisai Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Eisai Key News & Latest Developments
Table 90. Exelixis Company Summary
Table 91. Exelixis Cancer Drug Therapy Product Offerings
Table 92. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Exelixis Key News & Latest Developments
Table 94. Genentech (Roche) Company Summary
Table 95. Genentech (Roche) Cancer Drug Therapy Product Offerings
Table 96. Genentech (Roche) Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Genentech (Roche) Key News & Latest Developments
Table 98. Novartis Company Summary
Table 99. Novartis Cancer Drug Therapy Product Offerings
Table 100. Novartis Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Novartis Key News & Latest Developments
Table 102. Pfizer Company Summary
Table 103. Pfizer Cancer Drug Therapy Product Offerings
Table 104. Pfizer Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Pfizer Key News & Latest Developments
Table 106. Prometheus Labs Company Summary
Table 107. Prometheus Labs Cancer Drug Therapy Product Offerings
Table 108. Prometheus Labs Cancer Drug Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Prometheus Labs Key News & Latest Developments
Table 110. Cancer Drug Therapy Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 111. Global Cancer Drug Therapy Capacity Market Share of Key Manufacturers, 2021-2023
Table 112. Global Cancer Drug Therapy Production by Region, 2018-2023 (K Units)
Table 113. Global Cancer Drug Therapy Production by Region, 2024-2029 (K Units)
Table 114. Cancer Drug Therapy Market Opportunities & Trends in Global Market
Table 115. Cancer Drug Therapy Market Drivers in Global Market
Table 116. Cancer Drug Therapy Market Restraints in Global Market
Table 117. Cancer Drug Therapy Raw Materials
Table 118. Cancer Drug Therapy Raw Materials Suppliers in Global Market
Table 119. Typical Cancer Drug Therapy Downstream
Table 120. Cancer Drug Therapy Downstream Clients in Global Market
Table 121. Cancer Drug Therapy Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Cancer Drug Therapy Segment by Type in 2022
Figure 2. Cancer Drug Therapy Segment by Application in 2022
Figure 3. Global Cancer Drug Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Drug Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Drug Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. Cancer Drug Therapy Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Cancer Drug Therapy Revenue in 2022
Figure 9. By Type - Global Cancer Drug Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Cancer Drug Therapy Revenue Market Share, 2018-2029
Figure 11. By Type - Global Cancer Drug Therapy Sales Market Share, 2018-2029
Figure 12. By Type - Global Cancer Drug Therapy Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Cancer Drug Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Cancer Drug Therapy Revenue Market Share, 2018-2029
Figure 15. By Application - Global Cancer Drug Therapy Sales Market Share, 2018-2029
Figure 16. By Application - Global Cancer Drug Therapy Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Cancer Drug Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Cancer Drug Therapy Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Cancer Drug Therapy Revenue Market Share, 2018-2029
Figure 20. By Region - Global Cancer Drug Therapy Sales Market Share, 2018-2029
Figure 21. By Country - North America Cancer Drug Therapy Revenue Market Share, 2018-2029
Figure 22. By Country - North America Cancer Drug Therapy Sales Market Share, 2018-2029
Figure 23. US Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Cancer Drug Therapy Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Cancer Drug Therapy Sales Market Share, 2018-2029
Figure 28. Germany Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. France Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Cancer Drug Therapy Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Cancer Drug Therapy Sales Market Share, 2018-2029
Figure 37. China Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. India Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Cancer Drug Therapy Revenue Market Share, 2018-2029
Figure 43. By Country - South America Cancer Drug Therapy Sales Market Share, 2018-2029
Figure 44. Brazil Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Cancer Drug Therapy Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Cancer Drug Therapy Sales Market Share, 2018-2029
Figure 48. Turkey Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Cancer Drug Therapy Revenue, (US$, Mn), 2018-2029
Figure 52. Global Cancer Drug Therapy Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Cancer Drug Therapy by Region, 2022 VS 2029
Figure 54. Cancer Drug Therapy Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ がん薬物治療の世界市場見通し2023年-2029年(Cancer Drug Therapy Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

がん薬物治療の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp